In March 2025, the company announced new designs for just a immediate-to-client supplying of its Wegovy weight loss drug. The company established a new pharmacy, referred to as NovoCare, which would demand prospects $499 a month for usage of the drug, fewer than half the price of the drug by way of other pharmaceutical distribution networks.[fifty